Potent antiplatelet drugs increase major bleeding risk in AF patients after heart attack
Potent antiplatelet therapy increased bleeding without signs of benefit regarding cardiovascular events in patients with atrial fibrillation after a heart attack. This was the main finding of the EPIDAURUS trial presented ...
Aug 31, 2026
0
8









